Thenga i-TARGIN X 28 TABLETS Ku-inthanethi | Yini esetshenziselwa | I-MushroomiFi.

Ithebhulethi yokukhululwa kwe-TARGIN iboniswe: 1. Ukuphathwa kobuhlungu obunzima lapho: ezinye izinketho zokwelashwa zihlulekile, ziphikisana, azibekezeleleki noma azifanelekile ukunikeza ukuphathwa okwanele kobuhlungu, futhi ubuhlungu buphendula i-opioid; futhi idinga ukwelashwa kwansuku zonke, okuqhubekayo, kwesikhathi eside. Ithebhulethi yokukhululwa eguquliwe ye-TARGIN ayiboniswa ukuthi isetshenziswe ezinhlungwini ezingapheli ezingezona umdlavuza ngaphandle kwezimo ezingavamile. Ithebhulethi ekhishwe eshintshiwe ye-TARGIN ayiboniswa njenge-analgesia njengoba kudingekile (PRN). Ingxenye ye-naloxone ekuhlanganisweni okungaguquki ne-oxycodone ikhonjiswe ekwelapheni kanye/noma i-prophylaxis ye-opioid-induced. ukuqunjelwa. ,2. Umugqa wesibili wokwelashwa okuyizimpawu zeziguli ezine-idiopathic enzima kuya kokuqina kakhulu imilenze engenasifo ngemuva kokwehluleka kokwelashwa kwe-dopaminergic. Thenga i-Targin oxycodone ku-inthanethi e-Australia

2. Ingxoxo yesayensi

2.1. Isingeniso

I-Oxynal 10mg/5mg, 20mg/10mg amaphilisi akhishwa isikhathi eside kanye neTargin 5mg/2.5mg, 10mg/5mg,
20mg/10mg, 40mg/20mg amaphilisi okukhululwa isikhathi eside namagama ahlobene (OXN PR) alungisiwe
imikhiqizo ehlanganisiwe ye-oxycodone hydrochloride ne-naloxone hydrochloride. I-Oxycodone iyi-opioid e-semisynthetic okuyi-narcotic analgesic evame ukukhonjiswa ukuze kukhululeke ubuhlungu obumaphakathi kuya kobunzima. Thenga i-Targin oxycodone ku-inthanethi e-Australia

I-Naloxone ingumphikisi we-opioid omsulwa ovame ukusetshenziselwa ukulwa nemiphumela ye-opioid overdose.
Kulokhu, yengeze ekulweni nokuqunjelwa okubangelwa i-opioid ngokuvimbela isenzo se-oxycodone
ama-opioid receptors endaweni emathunjini. Thenga i-Targin oxycodone ku-inthanethi e-Australia
I-OXN PR okwamanje ikhonjiswe “ezinhlungwini ezinzima, ezingaphathwa ngendlela efanele kuphela nge-opioid
ama-analgesics". Thenga i-Targin oxycodone ku-inthanethi e-Australia

Enqubweni yokwehluka i-MAH yafaka isicelo sokuthi i-OXN PR isetshenziswe “ekulapheni okuyizimpawu ze
iziguli ezine-idiopathic restless legs syndrome ephakathi nendawo ukuya kokuqina engelashwanga ngokwanele
ukwelashwa kwe-dopaminergic". Ngesikhathi senqubo yokudluliselwa kwe-CMD(h), i-rerestless legs syndrome ehlongozwayo
inkomba yayilinganiselwe “ekulapheni okungokophawu komugqa wesibili weziguli ezinobunzima obukhulu ukuya kobunzima kakhulu
I-idiopathic restless legs syndrome ngemuva kokwehluleka kokwelashwa kwe-dopaminergic ”.

Ngokulandela inqubo ye-CMD(h) yezinsuku ezingama-60, i-Netherlands yayinombono wokuthi ingozi yenzuzo
ibhalansi ye-OXN PR yenkomba ekhawulelwe isabhekwa njengenegethivu. Imininingwane yomtholampilo etholakalayo,
ulwazi lomkhiqizo oluhlongoziwe oluhlongozwayo kanye nesilinganiso esihlongozwayo sokunciphisa ubungozi azanele
ukuqinisekisa ukuthi ubungozi bokuncika ezidakamizweni ze-iatrogenic kanye nokusetshenziswa kabi kwemithi kadokotela kuyayidlula. Thenga i-Targin oxycodone ku-inthanethi e-Australia